News

One year later: Group Health Centre still has 7,000 people waiting for a primary care provider
Thousands of people in Sault Ste. Marie, Ont., continue to rely on a temporary nurse practitioner clinic set up after the ...
Follow our live coverage of the last day of Delaware's legislative session
Follow along here with Delaware Online/The News Journal as several reporters cover the final day in Delaware's Legislative ...
New York’s tech elite are melting down over the election of Zohran Mamdani. Is the city destined for a San Francisco-style rebellion?
For those of us in the trenches of X, the meltdown was a familiar sight, echoing the contempt that the tech elite have ...
Weighing the Costs of Tax Cuts, Medicaid and ‘Debt Slavery’
As the Senate prepares to vote on a key piece of the president’s domestic agenda, prominent critics, including Elon Musk, are ...
Crain's New York Business7h
Some business leaders make peace with Mamdani as others plot against him
Zohran Mamdani’s upset win in last week’s mayoral primary sent the business world reeling and has fueled plots to fund a ...
Zohran Mamdani has Dems in ‘absolute panic’ over how to handle NYC mayoral bid: Endorse ‘toxic’ brand or risk primary challenge
Democrats are in “absolute panic” over Zohran Mamdani’s stunning New York City Democratic mayoral primary win — fearing he ...
The Latest: July deadline for Trump’s tax and spending bill approaches
Monday could be a pivotal day for Senate Republicans, who are racing to meet President Donald Trump’s Fourth of July deadline ...
Venezuelan who had rare, major surgery was deported to El Salvador prison, and his family has no idea how he is
Wladimir Vera Villamizar, a 33-year-old welder, had a whole lung removed — an uncommon procedure that requires months of ...
With Don Bacon's retirement, Nebraska Republicans confirm interest in 2nd District race
With Rep. Don Bacon's official retirement announcement Monday, three Omaha Republicans confirmed that they're interested in ...
Finanznachrichten15h
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
Global Phase 3 PROMINENT study will evaluate the efficacy and safety of felzartamab, as compared to tacrolimus, in adults with primary membranous nephropathy (PMN) There are currently no therapies ...